从透析到旅行:CKD患者安全旅行策略
本综述针对CKD及ESKD患者,梳理了航空与长途旅行相关的心血管、血栓、感染、时差及血管通路风险,并评估了主要航空公司的医疗许可流程。文章为血透和腹透患者提供了行前评估、药物与耗材管理、国际透析协调及飞行中预防措施的具体建议。
要点
- CKD与透析患者旅行需行前评估心血管、感染及血管通路风险。
- 航空旅行需关注低压性低氧血症和静脉血栓栓塞症(VTE)风险。
- 血透和腹透患者应提前协调国际透析并管理药物与耗材。
核心结论
- CKD及透析患者旅行需个体化评估与准备以降低并发症风险。
研究设计与样本
- 综述,检索并汇总CKD与透析患者旅行相关并发症及航空医学文献。
主要发现
- 旅行相关风险包括心血管事件、血栓栓塞、感染、时差及血管通路风险。
- 航空医学关注低压性低氧血症和静脉血栓栓塞症(VTE)。
- 评估了主要全球航空公司的医疗许可协议。
关键数值与推荐
- 为血透和腹透患者提供行前评估、药物与耗材管理、国际透析协调及飞行中预防措施建议。
临床怎么用
- 临床医生应协助CKD及透析患者行前评估并制定个体化旅行计划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic kidney disease (CKD) and end-stage kidney disease (ESKD) represent growing global health burdens, driven by aging populations and increasing prevalence of diabetes and hypertension. Patients with ESKD face significant lifestyle limitations, particularly regarding mobility and travel, because of treatment schedules, medical complexity, and heightened vulnerability to complications. Air and long-distance travel pose distinct risks-cardiovascular stress, infection, and logistical challenges-that demand tailored assessment and preparation. This review outlines key travel-related complications in CKD and patients on dialysis, including cardiovascular and thromboembolic events, infection, jet lag, and vascular access risks. It further examines aeromedical considerations, such as hypobaric hypoxemia and venous thromboembolism (VTE), and evaluates airline-specific medical clearance protocols in major global carriers. Detailed recommendations are provided for hemodialysis and peritoneal dialysis (PD) patients, including pre-travel assessment, medication and supply management, international dialysis coordination, and inflight precautions.
引用
- Kim SG, Chao CT, Vareesangthip K, et al. From Dialysis to Destinations: Safe Travel Strategies for Patients With CKD. Kidney Int Rep. 2025. PMID: 41426034. doi:10.1016/j.ekir.2025.09.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。